Data is at the heart of applicable genomics. As the volume and depth of genomic data grows, bioinformaticians are translating the data into interpretable patterns leading to new biological insight.
This week: Consider how your DNA could make you less secure, learn about how a controversial doctor from Massachusetts General Hospital is helping to improve diabetes treatment, and get all the details of the next big Hacakthon in San Francisco!
A survey of people who have taken part in clinical trials indicates that participants care more about the benefits to science than the risk of sharing their personal data.
Researchers have developed a new method for correcting the errors that creep into DNA barcodes, yielding far more accurate results and paving the way for more ambitious medical research in the future.
Using artificial intelligence, digital therapeutics, and genomics, these are the top five startups that are disrupting U.S. healthcare today.
To understand the biology of diseased organs, researchers can use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types.
Computational researchers have developed a computer program which has revealed a previously unknown combination of drugs that may be the answer to triple-negative breast cancer.
When it comes to understanding what makes people tick—and get sick—medical science has long assumed that the bigger the sample of human subjects, the better. New research suggests this big data approach may be wildly off the mark.
Genomic data company, Fabric Genomics have said its proprietary clinical genomics platform has been selected by 10 new commercial partners across Africa, Asia, Europe and North America.
Researchers have assembled the genomes of an orang-utan and a chimpanzee without incorporating any human DNA for the first time, allowing for a more accurate evaluation of their genotypes.
Probably not. But there is an increasing demand for people with data and computing skills, and the life sciences sector in California may be losing the battle with Silicon Valley for those people.
Microbiotica has entered into a multi-year strategic collaboration with Genentech, a Roche company, to discover, develop, and commercialise biomarkers, targets, and medicines for inflammatory bowel disease.
The study of viral ecology is taking major leaps forward with the use of long-read sequencing and viral metagenomics. On this webinar we discuss how MinION technology is bringing scientists closer to high-throughput single-virus genomics from environmental samples.
A security breach at DNA testing website MyHeritage have leaked the data of over 92 million users, the company said on Monday.
The NIH has announced their strategic plan for data science for the next 5 years, and their intention to hire their first Chief Data Strategist to oversee and implement their goals.
People’s medical and health history might become more than just a blueprint for doctor’s actions, now that blockchain start-up Nebula Genomics, and Hong Kong-based Longenesis are partnering up.
